Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.
Derosa CA, Furusato B, Shaheduzzaman S, Srikantan V, Wang Z, Chen Y, Seifert M, Ravindranath L, Young D, Nau M, Dobi A, Werner T, McLeod DG, Vahey MT, Sesterhenn IA, Srivastava S, Petrovics G.
Derosa CA, et al. Among authors: young d.
Prostate Cancer Prostatic Dis. 2012 Jun;15(2):150-6. doi: 10.1038/pcan.2011.61. Epub 2011 Nov 29.
Prostate Cancer Prostatic Dis. 2012.
PMID: 22343836